Copyright Reports & Markets. All rights reserved.

Global Injectable Skin Fillers Market Research Report 2021

Request for Sample of this report
Buy now

1 Injectable Skin Fillers Market Overview

  • 1.1 Product Overview and Scope of Injectable Skin Fillers
  • 1.2 Injectable Skin Fillers Segment by Type
    • 1.2.1 Global Injectable Skin Fillers Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Hyaluronic Acid
    • 1.2.3 Collagen
    • 1.2.4 Artecoll
    • 1.2.5 CaHA
    • 1.2.6 Others
  • 1.3 Injectable Skin Fillers Segment by Application
    • 1.3.1 Global Injectable Skin Fillers Sales Comparison by Application: (2021-2027)
    • 1.3.2 Specialist and Dermatology Clinic
    • 1.3.3 Hospitals and Clinics
    • 1.3.4 Others
  • 1.4 Global Injectable Skin Fillers Market Size Estimates and Forecasts
    • 1.4.1 Global Injectable Skin Fillers Revenue 2016-2027
    • 1.4.2 Global Injectable Skin Fillers Sales 2016-2027
    • 1.4.3 Injectable Skin Fillers Market Size by Region: 2016 Versus 2021 Versus 2027

2 Injectable Skin Fillers Market Competition by Manufacturers

  • 2.1 Global Injectable Skin Fillers Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Injectable Skin Fillers Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Injectable Skin Fillers Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Injectable Skin Fillers Manufacturing Sites, Area Served, Product Type
  • 2.5 Injectable Skin Fillers Market Competitive Situation and Trends
    • 2.5.1 Injectable Skin Fillers Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Injectable Skin Fillers Players Market Share by Revenue
    • 2.5.3 Global Injectable Skin Fillers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Skin Fillers Retrospective Market Scenario by Region

  • 3.1 Global Injectable Skin Fillers Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Injectable Skin Fillers Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Injectable Skin Fillers Market Facts & Figures by Country
    • 3.3.1 North America Injectable Skin Fillers Sales by Country
    • 3.3.2 North America Injectable Skin Fillers Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Injectable Skin Fillers Market Facts & Figures by Country
    • 3.4.1 Europe Injectable Skin Fillers Sales by Country
    • 3.4.2 Europe Injectable Skin Fillers Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Injectable Skin Fillers Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Injectable Skin Fillers Sales by Region
    • 3.5.2 Asia Pacific Injectable Skin Fillers Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Injectable Skin Fillers Market Facts & Figures by Country
    • 3.6.1 Latin America Injectable Skin Fillers Sales by Country
    • 3.6.2 Latin America Injectable Skin Fillers Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Injectable Skin Fillers Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Injectable Skin Fillers Sales by Country
    • 3.7.2 Middle East and Africa Injectable Skin Fillers Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Injectable Skin Fillers Historic Market Analysis by Type

  • 4.1 Global Injectable Skin Fillers Sales Market Share by Type (2016-2021)
  • 4.2 Global Injectable Skin Fillers Revenue Market Share by Type (2016-2021)
  • 4.3 Global Injectable Skin Fillers Price by Type (2016-2021)

5 Global Injectable Skin Fillers Historic Market Analysis by Application

  • 5.1 Global Injectable Skin Fillers Sales Market Share by Application (2016-2021)
  • 5.2 Global Injectable Skin Fillers Revenue Market Share by Application (2016-2021)
  • 5.3 Global Injectable Skin Fillers Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Allergan
    • 6.1.1 Allergan Corporation Information
    • 6.1.2 Allergan Description and Business Overview
    • 6.1.3 Allergan Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Allergan Injectable Skin Fillers Product Portfolio
    • 6.1.5 Allergan Recent Developments/Updates
  • 6.2 Galderma
    • 6.2.1 Galderma Corporation Information
    • 6.2.2 Galderma Description and Business Overview
    • 6.2.3 Galderma Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Galderma Injectable Skin Fillers Product Portfolio
    • 6.2.5 Galderma Recent Developments/Updates
  • 6.3 LG Life Sciences
    • 6.3.1 LG Life Sciences Corporation Information
    • 6.3.2 LG Life Sciences Description and Business Overview
    • 6.3.3 LG Life Sciences Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 LG Life Sciences Injectable Skin Fillers Product Portfolio
    • 6.3.5 LG Life Sciences Recent Developments/Updates
  • 6.4 Merz
    • 6.4.1 Merz Corporation Information
    • 6.4.2 Merz Description and Business Overview
    • 6.4.3 Merz Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merz Injectable Skin Fillers Product Portfolio
    • 6.4.5 Merz Recent Developments/Updates
  • 6.5 Medytox
    • 6.5.1 Medytox Corporation Information
    • 6.5.2 Medytox Description and Business Overview
    • 6.5.3 Medytox Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Medytox Injectable Skin Fillers Product Portfolio
    • 6.5.5 Medytox Recent Developments/Updates
  • 6.6 HUGEL
    • 6.6.1 HUGEL Corporation Information
    • 6.6.2 HUGEL Description and Business Overview
    • 6.6.3 HUGEL Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 HUGEL Injectable Skin Fillers Product Portfolio
    • 6.6.5 HUGEL Recent Developments/Updates
  • 6.7 Croma-Pharma GmbH
    • 6.6.1 Croma-Pharma GmbH Corporation Information
    • 6.6.2 Croma-Pharma GmbH Description and Business Overview
    • 6.6.3 Croma-Pharma GmbH Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Croma-Pharma GmbH Injectable Skin Fillers Product Portfolio
    • 6.7.5 Croma-Pharma GmbH Recent Developments/Updates
  • 6.8 Beijing IMEIK
    • 6.8.1 Beijing IMEIK Corporation Information
    • 6.8.2 Beijing IMEIK Description and Business Overview
    • 6.8.3 Beijing IMEIK Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Beijing IMEIK Injectable Skin Fillers Product Portfolio
    • 6.8.5 Beijing IMEIK Recent Developments/Updates
  • 6.9 Bloomage BioTechnology
    • 6.9.1 Bloomage BioTechnology Corporation Information
    • 6.9.2 Bloomage BioTechnology Description and Business Overview
    • 6.9.3 Bloomage BioTechnology Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Bloomage BioTechnology Injectable Skin Fillers Product Portfolio
    • 6.9.5 Bloomage BioTechnology Recent Developments/Updates
  • 6.10 Elravie (Humedix)
    • 6.10.1 Elravie (Humedix) Corporation Information
    • 6.10.2 Elravie (Humedix) Description and Business Overview
    • 6.10.3 Elravie (Humedix) Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Elravie (Humedix) Injectable Skin Fillers Product Portfolio
    • 6.10.5 Elravie (Humedix) Recent Developments/Updates
  • 6.11 Cleviel (Pharma Research Products)
    • 6.11.1 Cleviel (Pharma Research Products) Corporation Information
    • 6.11.2 Cleviel (Pharma Research Products) Injectable Skin Fillers Description and Business Overview
    • 6.11.3 Cleviel (Pharma Research Products) Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Cleviel (Pharma Research Products) Injectable Skin Fillers Product Portfolio
    • 6.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
  • 6.12 Haohai Biological Technology
    • 6.12.1 Haohai Biological Technology Corporation Information
    • 6.12.2 Haohai Biological Technology Injectable Skin Fillers Description and Business Overview
    • 6.12.3 Haohai Biological Technology Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Haohai Biological Technology Injectable Skin Fillers Product Portfolio
    • 6.12.5 Haohai Biological Technology Recent Developments/Updates
  • 6.13 Q.O.Fill (JW Pharmaceutical)
    • 6.13.1 Q.O.Fill (JW Pharmaceutical) Corporation Information
    • 6.13.2 Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Description and Business Overview
    • 6.13.3 Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Product Portfolio
    • 6.13.5 Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
  • 6.14 Teoxane
    • 6.14.1 Teoxane Corporation Information
    • 6.14.2 Teoxane Injectable Skin Fillers Description and Business Overview
    • 6.14.3 Teoxane Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Teoxane Injectable Skin Fillers Product Portfolio
    • 6.14.5 Teoxane Recent Developments/Updates
  • 6.15 Sinclair
    • 6.15.1 Sinclair Corporation Information
    • 6.15.2 Sinclair Injectable Skin Fillers Description and Business Overview
    • 6.15.3 Sinclair Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Sinclair Injectable Skin Fillers Product Portfolio
    • 6.15.5 Sinclair Recent Developments/Updates
  • 6.16 Suneva Medical
    • 6.16.1 Suneva Medical Corporation Information
    • 6.16.2 Suneva Medical Injectable Skin Fillers Description and Business Overview
    • 6.16.3 Suneva Medical Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Suneva Medical Injectable Skin Fillers Product Portfolio
    • 6.16.5 Suneva Medical Recent Developments/Updates
  • 6.17 Prollenium
    • 6.17.1 Prollenium Corporation Information
    • 6.17.2 Prollenium Injectable Skin Fillers Description and Business Overview
    • 6.17.3 Prollenium Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Prollenium Injectable Skin Fillers Product Portfolio
    • 6.17.5 Prollenium Recent Developments/Updates
  • 6.18 S&V Technologies GMBH
    • 6.18.1 S&V Technologies GMBH Corporation Information
    • 6.18.2 S&V Technologies GMBH Injectable Skin Fillers Description and Business Overview
    • 6.18.3 S&V Technologies GMBH Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 S&V Technologies GMBH Injectable Skin Fillers Product Portfolio
    • 6.18.5 S&V Technologies GMBH Recent Developments/Updates
  • 6.19 Luminera
    • 6.19.1 Luminera Corporation Information
    • 6.19.2 Luminera Injectable Skin Fillers Description and Business Overview
    • 6.19.3 Luminera Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Luminera Injectable Skin Fillers Product Portfolio
    • 6.19.5 Luminera Recent Developments/Updates
  • 6.20 Matex-Lab
    • 6.20.1 Matex-Lab Corporation Information
    • 6.20.2 Matex-Lab Injectable Skin Fillers Description and Business Overview
    • 6.20.3 Matex-Lab Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Matex-Lab Injectable Skin Fillers Product Portfolio
    • 6.20.5 Matex-Lab Recent Developments/Updates
  • 6.21 Caregen
    • 6.21.1 Caregen Corporation Information
    • 6.21.2 Caregen Injectable Skin Fillers Description and Business Overview
    • 6.21.3 Caregen Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Caregen Injectable Skin Fillers Product Portfolio
    • 6.21.5 Caregen Recent Developments/Updates
  • 6.22 CG Bio
    • 6.22.1 CG Bio Corporation Information
    • 6.22.2 CG Bio Injectable Skin Fillers Description and Business Overview
    • 6.22.3 CG Bio Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 CG Bio Injectable Skin Fillers Product Portfolio
    • 6.22.5 CG Bio Recent Developments/Updates
  • 6.23 BioPlus
    • 6.23.1 BioPlus Corporation Information
    • 6.23.2 BioPlus Injectable Skin Fillers Description and Business Overview
    • 6.23.3 BioPlus Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 BioPlus Injectable Skin Fillers Product Portfolio
    • 6.23.5 BioPlus Recent Developments/Updates
  • 6.24 SciVision Biotech
    • 6.24.1 SciVision Biotech Corporation Information
    • 6.24.2 SciVision Biotech Injectable Skin Fillers Description and Business Overview
    • 6.24.3 SciVision Biotech Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 SciVision Biotech Injectable Skin Fillers Product Portfolio
    • 6.24.5 SciVision Biotech Recent Developments/Updates
  • 6.25 Jingjia Medical
    • 6.25.1 Jingjia Medical Corporation Information
    • 6.25.2 Jingjia Medical Injectable Skin Fillers Description and Business Overview
    • 6.25.3 Jingjia Medical Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 Jingjia Medical Injectable Skin Fillers Product Portfolio
    • 6.25.5 Jingjia Medical Recent Developments/Updates
  • 6.26 BioScience
    • 6.26.1 BioScience Corporation Information
    • 6.26.2 BioScience Injectable Skin Fillers Description and Business Overview
    • 6.26.3 BioScience Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.26.4 BioScience Injectable Skin Fillers Product Portfolio
    • 6.26.5 BioScience Recent Developments/Updates
  • 6.27 Genoss
    • 6.27.1 Genoss Corporation Information
    • 6.27.2 Genoss Injectable Skin Fillers Description and Business Overview
    • 6.27.3 Genoss Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.27.4 Genoss Injectable Skin Fillers Product Portfolio
    • 6.27.5 Genoss Recent Developments/Updates
  • 6.28 Laboratory Thoscane LLC
    • 6.28.1 Laboratory Thoscane LLC Corporation Information
    • 6.28.2 Laboratory Thoscane LLC Injectable Skin Fillers Description and Business Overview
    • 6.28.3 Laboratory Thoscane LLC Injectable Skin Fillers Sales, Revenue and Gross Margin (2016-2021)
    • 6.28.4 Laboratory Thoscane LLC Injectable Skin Fillers Product Portfolio
    • 6.28.5 Laboratory Thoscane LLC Recent Developments/Updates

7 Injectable Skin Fillers Manufacturing Cost Analysis

  • 7.1 Injectable Skin Fillers Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Injectable Skin Fillers
  • 7.4 Injectable Skin Fillers Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Injectable Skin Fillers Distributors List
  • 8.3 Injectable Skin Fillers Customers

9 Injectable Skin Fillers Market Dynamics

  • 9.1 Injectable Skin Fillers Industry Trends
  • 9.2 Injectable Skin Fillers Growth Drivers
  • 9.3 Injectable Skin Fillers Market Challenges
  • 9.4 Injectable Skin Fillers Market Restraints

10 Global Market Forecast

  • 10.1 Injectable Skin Fillers Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Injectable Skin Fillers by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Injectable Skin Fillers by Type (2022-2027)
  • 10.2 Injectable Skin Fillers Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Injectable Skin Fillers by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Injectable Skin Fillers by Application (2022-2027)
  • 10.3 Injectable Skin Fillers Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Injectable Skin Fillers by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Injectable Skin Fillers by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Hyaluronic Acid
    Collagen
    Artecoll
    CaHA
    Others

    Segment by Application
    Specialist and Dermatology Clinic
    Hospitals and Clinics
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Allergan
    Galderma
    LG Life Sciences
    Merz
    Medytox
    HUGEL
    Croma-Pharma GmbH
    Beijing IMEIK
    Bloomage BioTechnology
    Elravie (Humedix)
    Cleviel (Pharma Research Products)
    Haohai Biological Technology
    Q.O.Fill (JW Pharmaceutical)
    Teoxane
    Sinclair
    Suneva Medical
    Prollenium
    S&V Technologies GMBH
    Luminera
    Matex-Lab
    Caregen
    CG Bio
    BioPlus
    SciVision Biotech
    Jingjia Medical
    BioScience
    Genoss
    Laboratory Thoscane LLC

    Buy now